Track topics on Twitter Track topics that are important to you
* Says Victor Grifols Roura to remain in the company as non executive chairman
Grifols says its board of directors has approved a plan for new industrial investments for the Bioscience…
Blood plasma product manufacturer Grifols is one of the first companies to profit from the newly launched European Fund for Strategic Investments (EFSI). The EIB will loan Grifols €100m over ten yea...
Spanish firm Grifols has reached a deal to purchase a 49% stake in the US plasma collector Interstate Blood Bank for about $1 -More-
The Board of Directors of Grifols, which met on February 26, has approved a plan for new industrial investments for the Bioscience division for the period 2016-2021, with the goal of expanding the man...
Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity and purification of the several proteins. The investment is for t...
Grifols invests €326 millions in four new plants, one in Parets del Vallès
A new web portal has been launched to provide a platform to promote the UK’s strengths and capabilities in medicines manufacturing. The portal is developed by the Knowledge Transfer Network (K...
One potential way that healthy organizations can impact employee health is by promoting a climate for health within the organization. Using a definition of health climate that includes support for hea...
Turnover hurts patient care quality and is expensive to hospitals. Improved employee engagement could encourage employees to stay at their organization.
To investigate the feasibility of estimating the portal vein blood volume that flows into the intrahepatic volume (IHPVBV) in each cardiac cycle using non-contrast MR venography technique as a surroga...
In order to provide whole-person care for patients and families, Loma Linda University Health recognizes the importance of supporting employee wholeness. The Employee Spiritual Care department helps c...
Thrombosis of the splenoportal axis not associated with liver cirrhosis or neoplasms is a rare disease whose prevalence ranges from 0.7 to 3.7 per 100,000 inhabitants. However, this entity is the seco...